Drug Shortage Report for TEVA-PROPRANOLOL
Report ID | 17976 |
Drug Identification Number | 00740675 |
Brand name | TEVA-PROPRANOLOL |
Common or Proper name | PROPRANOLOL |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | PROPRANOLOL HYDROCHLORIDE |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C07AA |
ATC description | BETA BLOCKING AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-08-30 |
Estimated end date | |
Actual end date | 2021-10-12 |
Shortage status | Resolved |
Updated date | 2021-10-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2021-10-14 | French | Compare |
v6 | 2021-10-14 | English | Compare |
v5 | 2017-10-10 | French | Compare |
v4 | 2017-10-10 | English | Compare |
v3 | 2017-08-16 | English | Compare |
v2 | 2017-08-02 | French | Compare |
v1 | 2017-08-02 | English | Compare |
Showing 1 to 7 of 7